Ricerca Biosciences, LLC and the Bicoll Group have signed a collaboration agreement that will combine their strengths in MedChem Services to offer solutions that streamline drug discovery and development. Ricerca has a network of business development representatives throughout the U.S. and it will leverage Bicoll’s medicinal chemistry and natural product chemistry technology for drug discovery to North American clients.

“We believe that the access to Bicoll’s unique natural product chemistry technology as well as its competence in supportive reporting and IP protection will further strengthen our broad portfolio as a successful solution provider for product and process development and testing services,” commented Thomas Bradshaw, chief executive officer of Ricerca. “Bicoll’s strong and reliable MedChem Services, conducted in China, will allow us to provide our clients with additional valuable support in drug discovery.”

“Joining forces, Bicoll and Ricerca will be able to provide high medicinal, natural product, and custom synthetic chemistry services with a competitive price range to their clients,” stated Dr. Kai Lamottke, general manager of Bicoll (Shanghai) Co. Ltd. “As a state-of-the-art R&D company for high-tech natural product chemistry and drug discovery, the Bicoll Group has experienced an intensive growth spurt over the past few years – with the strong marketing partnership of Ricerca within North America we will now be able to provide our services together not only to European pharmaceutical customers, but to clients worldwide.”